Organization · Venture Capital
30Ventures
30Ventures was an early-stage venture capital firm based in the Midwest, focusing on healthcare and biotechnology companies. It aimed to support capital-efficient ventures, particularly in post-seed rounds.
Overview
What 30Ventures does
What 30Ventures is
30Ventures was an early-stage venture capital firm based in the Midwest, focusing on healthcare and biotechnology companies. It aimed to support capital-efficient ventures, particularly in post-seed rounds.
How it participates in the startup ecosystem
The current public profile supports funder capabilities. Each capability below is shown separately so organization identity and role-specific information do not get conflated.
Operational profile
Organization status and context
Organization status describes the entity itself. Funding and program availability appear within the relevant capability profile.
- Operational status
- Active
- Organization type
- Venture Capital
- Structured capabilities
- Funder
- Last reviewed
- April 29, 2026
Official channels
Find 30Ventures elsewhere
Open the official website or a supported primary organization account.
Capability profile
30Ventures as a funder
Investment thesis
30Ventures historically focused on investing in post-seed healthcare and biotech companies that could progress efficiently in the Midwest, emphasizing capital efficiency and reduced dilution compared to coastal fundraising.
Focus narrative
The firm focused on early-stage investments in healthcare and biotechnology, particularly in the Midwest. It aimed to support companies that could achieve significant milestones with less capital than their coastal counterparts, emphasizing the importance of scientific and clinical assets in their investment strategy.
Value beyond capital
30Ventures provided not only capital but also operational and scientific support to its portfolio companies, leveraging the extensive experience of its partners in healthcare and technology to help founders navigate the complexities of the biotech landscape.
Focus and fit
- Stages
- Seed · Seed+ · Series A · Series B
- Sectors
- Biotech · Healthcare · Digital Health · Medical Devices · Diagnostics
- Regions
- North AmericaUnited States
Availability
- Currently deploying
- No
Portfolio and track record
Portfolio context
Notable portfolio companies include Opsis Therapeutics, a regenerative medicine company specializing in retinal cell therapy; Cellara, focused on biotechnology and cell therapy; CultureTrax, a company listed in investment databases; Prevacept Infection Control, and Stem Pharm, both recognized in third-party portfolio datasets.
Common questions
What to know about 30Ventures
Upseed classifies 30Ventures under the Venture Capital organization type. Its current public profile includes funder capabilities.
Source and update disclosure
Know what this page is based on
Source basis
Public organization and program material, official websites, and structured Upseed records.
Last reviewed
April 29, 2026
Known limits
Capability profiles appear only when a structured public profile also contains decision-useful role evidence. Terms and availability can change.
Upseed is an independent guide. It is not affiliated with or endorsed by the organization described on this page.